09:35 AM EST - Goodbody Health Inc : Announced that its subsidiary, PhytoVista Laboratories, has been granted a controlled drugs licence that allows the company to handle up to Schedule 1 Controlled Drugs. This comes as the UK authorities look to the regulation of the UK consumer cannabinoid product testing infrastructure ahead of wider compliance within the industry. PhytoVista is one of a small number of laboratories accredited by the UK National Accreditation Service with extended provisions to carry out these specialist activities. Goodbody Health Inc
shares C.GDBY are trading down 9% at $0.05.
